Reply to a question regarding ovarian cancer prevention with partial salpingectomy vs complete

Am J Obstet Gynecol. 2021 Dec;225(6):694-695. doi: 10.1016/j.ajog.2021.06.085. Epub 2021 Jun 30.

Authors

Greg Marchand¹, Kerry Mills², Kelly Ware³

Affiliations

¹ Marchand Institute for Minimally Invasive Surgery, Mesa, AZ. Electronic address: gm@marchandinstitute.org.
² Marchand Institute for Minimally Invasive Surgery, Mesa, AZ; Faculty of Science and Technology, University of Canberra, Canberra, Australia.
³ Marchand Institute for Minimally Invasive Surgery, Mesa, AZ; International University of the Health Sciences, Basseterre, St. Kitts.

PMID: 34216567
DOI: 10.1016/j.ajog.2021.06.085

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Ovarian Epithelial
Female
Humans
Ovarian Neoplasms* / prevention & control
Ovarian Neoplasms* / surgery
Salpingectomy*